0.03Open0.03Pre Close0 Volume176 Open Interest1.00Strike Price0.00Turnover662.42%IV139.53%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.2236Delta0.9331Gamma14.34Leverage Ratio-0.0102Theta0.0000Rho3.21Eff Leverage0.0001Vega
Bionano Genomics Stock Discussion
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
Benzinga· just
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
No comment yet